Study on the Efficacy of Combination Drugs of Schisantherin A and Sorafenib in the Treatment of Drug Resistance in Advanced Hepatocellular Carcinoma

Abstract

Sorafenib (So) is a new multi-targeted first-line oral drug for the treatment of advanced hepatocel-*